FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Deese Willie A 		2. Issuer Name and Ticker or Trading Symbol

DENTSPLY SIRONA Inc. [ XRAY ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

221 WEST PHILADELPHIA STREET, SUITE 60W 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/20/2017
(Street)

YORK, PA 17401
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/20/2017     M    1441   A $0   4373   D    
Common Stock   5/21/2017     M    1412   A $0   5785   D    
Common Stock   5/22/2017     M    1601   A $0   7386   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RSU (Restricted Stock Unit)   $0   (1) 5/20/2017     M         1441   (2)     (3)   (3) Common Stock   1441   $0   4235.015   D    
RSU (Restricted Stock Unit)   $0   (1) 5/21/2017     M         1412   (4)     (5)   (5) Common Stock   1412   $0   2823.015   D    
RSU (Restricted Stock Unit)   $0   (1) 5/22/2017     M         1601   (6)     (5)   (5) Common Stock   1601   $0   1222.015   D    

Explanation of Responses:
(1)  Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration.
(2)  Comprised of one thousand four hundred twenty-six (1,426) vested RSUs plus fifteen (15) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II.
(3)  Restricted Stock Units vest in full one year from date of grant.
(4)  Comprised of one thousand three hundred ninety (1,390) vested RSUs plus twenty-two (22) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II.
(5)  Restricted Stock Units vest in full three (3) years from date of grant.
(6)  Comprised of one thousand five hundred sixty-seven (1,567) vested RSUs plus thirty-four (34) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Deese Willie A
221 WEST PHILADELPHIA STREET
SUITE 60W
YORK, PA 17401 		X



Signatures
Michael Friedlander, Attorney-In-Fact for Willie A. Deese 5/23/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DENTSPLY SIRONA Charts.